In addition to impaired insulin secretion, type 2 diabetic patients ... who identified insulin as the anti-diabetic factor produced by the pancreas. This discovery changed the once fatal diagnosis ...

Glucagon-like peptide 1 (GLP-1) could be a key factor driving the development of insulin-producing cells, according to in vitro data published in the journal Pancreas. The use of islet-cell ...

Researchers at IISc Bengaluru discover potential drug-free treatment for diabetes by enhancing beta-cell function with small ...

Researchers from Lund University, in collaboration with Newcastle University, have uncovered a potential breakthrough in ...

Researchers from Lund University and Newcastle University have found that the protein IGFBP7 can impair the function of beta ...

For several years, Lena Eliasson's research group has explored mechanisms that regulate insulin secretion from beta cells situated in the islets of Langerhans within the pancreas. Together with ...

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

Our perspective about glucose toxicity as it pertains to the pancreatic ß-cell is that the characteristic decreases in insulin synthesis and secretion ... defect in pancreas duodenum homeobox ...

This is a useful study that seeks to address the role of the TET family of DNA demethylation enzymes in pancreatic beta cell senescence in the context of type 2 diabetes (T2DM). Although the concepts ...

Findings suggest targeting neuro-immune pathway could lead to strategies for managing diabetes, obesity or some types of ...

New study shows that the gene G6PC2 plays an important role in regulating glucagon, a hormone that raises blood sugar levels.